Did we miss something? Our COVID-19 Collection is growing, but not yet complete. Tell us what's missing. Email contact@fairsharing.org or add missing resources to our spreadsheet

Ontology of Drug Neuropathy Adverse Events

Abbreviation: ODNAE

General Information

The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms, and drug-inducing neuropathy AEs. ODNAE is a platform for building a drug-induced neuropathy knowledge base and for analyzing the underlying mechanisms of drug-induced neuropathy. The ODNAE-based methods used in this study can also be extended to the representation and study of other categories of adverse events.

Homepage https://github.com/odnae/odnae

Countries that developed this resource United States

Created in 2016

Taxonomic range

Homo sapiens

Knowledge Domains

Subjects

User-defined Tags

Approved drug

How to cite this record FAIRsharing.org: ODNAE; Ontology of Drug Neuropathy Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.ddmatg; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Aug 14 2020 1:11 a.m.

This record is maintained by yongqunh

Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 20, 2018, 2:24 p.m. by The FAIRsharing Team.

Show edit history

Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 14:24, 20 Feb 2018 (approved):

	'contactName' has been modified:
		Before:
			Oliver He
		After:
			Yongqhun He
		Added:
		Removed:

Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 13:44, 19 Feb 2018 (approved):

	'description' has been modified:
		Before: ODNAE is an extension of OAE with a focus on drug-associated neuropathy adverse events.
		After: The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms, and drug-inducing neuropathy AEs. ODNAE is a platform for building a drug-induced neuropathy knowledge base and for analyzing the underlying mechanisms of drug-induced neuropathy. The ODNAE-based methods used in this study can also be extended to the representation and study of other categories of adverse events.

Support

No support information provided.

Additional Information

Contact

Yongqhun He ORCID

External Links

Bioportal

http://bioportal.bioontology.org/ontologies/ODNAE

Tools

No tools defined

Schemas

No XSD schemas defined

Access / Retrieve Data

Conditions of Use

Applies to: Data use

Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Publications

Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.

Guo A,Racz R,Hur J,Lin Y,Xiang Z,Zhao L,Rinder J,Jiang G,Zhu Q,He Y
J Biomed Semantics 2016

View Paper (PubMed) View Publication

ODNAE Ontology Display

View in BioPortal.

Disclaimer: This widget assumes the availability of the ontology resources in the NCBO BioPortal.

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined

Metrics

No metrics standards defined

Related Databases (0)

No Related Databases

Implementing Policies

This record is not implemented by any policy.

Credit

Record Maintainer

This record is maintained by yongqunh

Maintains

Mayo Clinic, Rochester, USA (Company)
School of Medicine and Health Sciences, University of North Dakota, Grand Forks, USA (University)
University of Michigan Medical School, USA (University)
University of Maryland, Baltimore, MD, USA (University)
He Group, University of Michigan Medical School, Ann Arbor, USA (Lab)

Ontology of Drug Neuropathy Adverse Events

We need your help!

Developed by

Contact Us

About FAIRsharing